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PART A.
MODEL FOR REGULATION OF ERYTHROPOIESIS
t1
Model for Regulation of Erythropoiesls
►.
J1.
A mathematical model of the erythropoiesis
regulating system was developed for use as a tool to
investigate the relative influence of the controlling
factors of erythropoiesis on total red blood cell
(R BC , mass The loss of red cell mass has been a
consistent finding during space flight and certain
ground-based analo gs of weightlessness such as bed
rest. Computer simulation of this phenomenon re-
quired a model that could account for oxygen
transport, red cell production, and red cell destru_-
tion.
The control of erythropoiesis is omenaoie to a
modeling approach, as demonstrated by a variety of
investigators These models have ranged from con-
ceptual, qualitative feedback schemes (refs 111-51
and III-52) to more de ailed mathematical descrip-
tions (ref Ill-:3), some of which have led to com-
puter simulation models (refs 111-8 and III-54).
Quar,tt;ati ,-e models have been developed for
dtffe:ent aspects of erythropoiesis regula:ion, in-
cluding ferrokineuc mod_!s (refs 111 . 5: and 111-56)
and those describing the control of stem. cell pro-
duction (refs III-57 to III-59).
A limited number of models are available that
integrate the entire feedback circuit in sufficient
detail to enable quand ative simulation of diverse
hematological stresses directly affecting oxygen
transport, tissue oxygenation, erythropoietin
release, and red cell production. Hodgson (ref.
111-53) has proposed such a model but apparently
has ocither implemented it for computer use nor
performed the studies necessary for validation An
algorithm capable of predicting red cell mass
changes by feedback processes was coupled to a
much larger mode! of circulatory and fluid control
(ref 111-8), but it provided only a gross representa-
tion of the renalftne-ma-row axis and failed to
recognize renal oxygenation as a major control ele-
men; The most complete simulatior mode! pre-
viously developed is that of Mylrea and Aborecht
(ref. 111-54); this model was validated for a single
stress (altitude hy-)oxia in mice).
A review of the factors that control
erythropoiesis and of existing models led to the for-
mulation of a conceptual model and eventually the
design and development of a computer model (ref.
111-60) The initial structure was derived from the
best features of the mathematical models of
Gcvton et al. (ref. 111-8), Hodgson (ref. I11-53). and
Mylrea and Abbrecht (ref. III-54). The model has a
wide range of applicability, the most important ap-
plication is its simulation of space-flight events
Model de.;criprion —Those elements in the feed-
back regulation loop that have been incorporated
into the model are shown schematically in figure
111 . 21 The formulation is based on the accepted
concept that erythrocyt- production is governed by
the balance between oxygen supply and demand in
the body and, in particular, at a renal sensing site.
The mechanisms and pathways of the control cir-
cuit include oxygenation of hemoglobin and ox-
ygenation of tissues by blood transport and diffu-
sicnal processes An erythrocyte-stimulating hor-
mone, erythropoietin, is produced and released at a
renal site in amounts that vary inversely with the
levels of tissue oxygen tension (pO:). Plasma levels
of eryth r opoietin control the production of
erythrocytes in the bone marrow. The amount of
circulating red cell mass is based on the addition of
new cells to existing cells with allrwance for the
destruction of older cells Blood hematocrit, an in-
dex of red cell concentration in whole blood, is
determined by dividing the circulating red cell mass
by the plasma volume. Other features of the model
include an oxygen-hernoglobin affinity, which can
be varied, and time delays which represent time for
erythropoietin distribution in plasma and time for
maturation of erythrocytes in the bone marrow.
*This section was originally written as part of a more comprehensive chapter
on physiological models which is as yet unpublished. Figures, tables,
equations, numbers, and references have been left intact from the original.
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In terms of control system theory, the controlled
system includes the elements of redistribution of
new cells, !ung oxygenation, blood transport, and
tissue oxygen extraction, whereas the controller
system consists of erythropoietin release, marrow
red cell production, and splenic destruction. The
hematocrit (or hemoglobin level) may be ron-
sidered to be the primary feedback quantity, and
the level of tissue oxygen>tion can be taken as the
directly controlled variable. Figure 111 -2 7. indicates
the input parameters which have been found most
useful in these studies, as well as the predicted out-
put responses which the model is capable of
generating. Appendix B and Section V contain a
more complete description of the model system.
Sensitivity analysis—The effect of variation of
the model parameters on the overall behavior of
the system can be studied by sensitivity analysis
techniques. (See app. A.) Sensitivity analysis is a
systematic method of evaluati ng the relative im-
portance of different parameters. Steady -state sen-
sitivity coefficients were estimated by varying each
of the most important parameters, one at a time, by
small increments around the normal control state.
Table 11I-6 contains the percent change in one de-
pendent variable (red all production rate) caused
by a l-percent decrease in the model parameters
(shown in the left column) and determined after a
new steady-state condition was reachert. Pos;tive
values of these coefficients indicate a response to a
hypoxic condition, and negative values indicate
response to tissue hyperoxia. In each case, the
response is in a direction that agrees with the con-
cepts of erythropoiesis regulation (ref. 11I-61). The
unusually high influence of oxygen uptake on red
blood cell production indicated may not be repre-
sentative of the real intact system. Compensatory
action by cardiorespiratory factors usually inter-
vene to normalize oxygen transport and thereby
limit the correction required by the erythropoietic
system (app. BY However, this analysis does sup-
port the assertion that, P50 shifts can dramatically
augment tissue oxygenation (refs. 111-62 and
111.63).
The results from a dynamic sensitivity analysis
are illustrated in figure 111-28 In this case, the six
most important parameters were changed by 10
percent in a direction that would initiate a hypoxic
response. The dynamic behavior of four important
dependent system variables during this constant
load disturbance is shown over a period of 30 days
It is apparent that the general ranking of parameter
TABLE 111-6.—Steady-Stare Sensitivity Coefficients°
Parowter (A&W M red n'll
petaidmirfof. peote It
Oxygen demand, le a — 1.55
OrHb afrinity, P50 3.90
Capillary difrusivity, K,, 3.25
Stood Rou, Q 1.15
Man corpuscular henioslobir 1.15
concentration, MCHC
Hernaalotim 10^ arryina apacity, 1.15
CtibO
Arterial O, tension, P.0 1 10
Plasma volume. PV 90
Red all half-life, TAWL .15
Controller pin, G —.03
h+alnp Own are peraenl chaflae in red ail prcdunuen at amadi mule due to e
I*oreeni dentraee in puameir value
importance found in the steady state is maintained
for the dynamic state as well. If, however, a new
equilibrium state was simulated for a specific hy-
poxia condition and sensitivity ooefficients were
obtained by small perturbations from that state,
both the magnitude and the ranking of the coeffi-
cients might be altered. Such behavior would not be
unexpected for a nonlinear mitrol system.
Figure 111-18 also illustrates the wide difference
in dynamic properties of the various elements in
the model. This model may be viewed as consisting
of four sequential processes, each with a charac-
teristic time constant that is correspondingly longer
wilt: respect to alterations in tissue oxygenation
(seconds to minutes), erythropoietin release
(hours), red all production (days), and red cell
mass (days to months). An interesting prediction
of these simulations is that the dynamic charac-
teristics of the hypoxic response are similar for a
vat iety of constant load disturbances, whether it be
an increase in plasma volume or a decra^e in renal
flow rate Unfortunately, the experiments required
to confirm this conclusioi are difficult to perform.
These simulation results should, therefore, be con-
sidered as model-to-model comparisons which
demonstrate that the mode! responds appropriately
in a gross sense to both equilibrium and dynamic
states
Model validation--Nlodel-to-data comparison is
a more challenging validation procoss which must
be used to establish ultimate credibility of any
A-3
A-4
model system The erythropoiesis control model
has been validated for long-term altitude hypoxia.
Buderer and Pace (ref. 111-64) studied the
dyaarnic changes in red cell mass, hematocrit, and
plasma volume in sea -level pigtailed monkeys dur-
ing 6 months at 3800 meters altitude followed by
descent to sea level for 3 months. Comparable dat:
for human subjects were not available. However,
the human model would not be expected to be fun-
damenta;:y different from that for a monkey at sea
level, especially if responses are expressed as nor-
malved values. The major driving function for the
model was an arterial blood oxygen tension of 6.7
and 12.7 kN/m' (50 and 95 mmHg) for the altitude
and sea-level phases, respectively. The model's
response was adjusted using the bone marrow con-
tro:ler gain until a visual "best fit" was obtained.
This is an example of parameter estimation. (See
app. E.) The c-)m- parison of model output and data
are illustrated in figure 111-29. In combination with
the arterial blood oxygen tension, the experimen-
tally determined change in plasma volume (bot•)m
curve) was used as a driver for the simulation, but
the effect on the overall response system for this
secondary load input was relatively small.
In addition to predicting the measured dynamic
changes of red cell mass and hematocrit, the model
is capable of predicting other system variables that
were not measured, vich as plasma erythropoietin
and red cell production-destruction rates. The
simulation shows the general sequence of events,
generall y assumed to characterize the hypoxic
response, including tissue hypoxia (not shown),
elevated erythropoietin, and augmented red cell
production levels, which increase the mass of cir-
culating blood cells (refs. I11-65 to II1-67). Figure
111-29 also shows the opposite scenario for the de-
scent phase. The difference between production
and destruction rates provides a visual indication of
the dynamic behavior of deviation from: steady
state. The slow approach to equilibrium at altitude
is also evident from the asvmpto6c nature of the
measumd quantities. Upon return to sea level, the
increased hematocrit serves as a prolonged
stimulus for tissue hyperoxis to the extent that red
cell production may be totally inhibited for several
weeks.
The erythropoietin response in humans and
mice is known to return toward control more
rapidl) than indicated in figure 111-29 (refs 111-65
and 111-68) Adaptive mechanisms of the circulato-
ry, ventilatory, and biochemical systems respond to
hypoxia and thereby improve oxygen transport
faster than does the more sluggish erythropoietic
system (ref. 111-69). Several simulations were per-
formed to trst the hypothesis that some of these
pathways contribute to the observed erythropoietin
response. Figure 111-30 illustrates the relative in-
fluence of three adaptive mechani:-ns (an increase
in p0: due to greater ventilation efficiency, a
decreased plasma volume, and a diminished ox-
yhemaglobin affinity) as predicted by the model.
These simulations, although not strictly a valida-
tion study, not only illustrate a more realistic
response but also indicate the manner in which
simulation techniques can be used to test hy-
potheses regarding physiological mechanisms.
Mouse model—Experiments with animals are
routinely conducted in support of space-flight
biomedical investigations. In particular, mice have
been examined for their potential use as experi-
mental models for the study of the early
erythropoietic disturbances found in astronauts
(ref. 111-70). The desirability of using a species-
specific model of erythropoiesis for predicting ex-
perimental results with animal subjects prompted
the formulation of a "mouse model." This model
was based on the human model but incorporated
parameter values that describe the unique charac-
teristics of the oxygen transport and erythropoietic
system for the mouse. Thus, red cell lifespan, ar-
terial oxygen tensicn, oxygen-hemoglobin affinity,
and many other parameters were found to differ
significantly from the human (ref. 111-71 and app.
B).
The mouse model was validated in a preliminary
study by examining its responses to hypoxia (ref.
111-70) and to erythropoietin infusions (ref. 111-12).
Ar example of the dynamic behavior of the mouse
model is provided in figure 111-31. In this simula-
tion, a pulse decrease in arterial oxygen tension
results in a corresponding disturbance in tissue ox-
ygen levels, followed by a short burst of
erythropoietin and a resulting crave of
erythropoiesis, the effects of which may last 2
weeks or longer. The transient nature of red cell
production shown here has been previously ob-
served after injectir-g erythropoietin into mice (ref.
I11-73). A similar simulation performed with the
human model results in more prolonged effects, as
indicated in figure 111-31. These ifferences result
primarily from the shorter erythropoietin disap-
pearance rates, red cell lifespan, and erythropoietin
half-life in the mouse when compared to the
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human. Simulations such as this suggest that some
information regarding erythropoiesis may be ob-
tained in a shorter time interval using the mouse as
an experimental model of the human.
Other simulations—Al though the major purpose
of the erythropoie6c control model was to investi-
gate mechanisms relati-I to the loss of red cells dur-
ing space (light, other applications have been
investigated to validate the model, to test hy-
potheses, and to introduce refinements. Table 111-7
is a summary of the major simulations ac-
complished with the human and mouse models
Human bed-rcst and mouse dehydration studies
have been found ;o be useful experimental analogs
of space-flight effects. A more recent area of model
development is in the simulation of hematological
disease states which have known physiological
etiologies (such as anemias, polycythemias, and ab-
normalities in hemr-globin functions) Toward this
end, a steady-state model based on the dynamic
model described previously has been formulated A
program is now in progress to develop a teaching
model of pathophysiology based on the human red
cell model.
Limitations—The erythropoiesis control system
model is the least complex of all the models de-
scribed in this section. Various features have been
added during its development to increase its simu-
lated realism. These have included elements repre-
senting erythropoietin release, cell maturation time
delays, and a variable oxygen-hemoglobin affinity.
Other limitations have been identified which either
are acceptable within the scope of this program or
form the basis for suggested improvements. These
limitations are summarized here.
1. Red cell oroduction is modulated by factors
other than those considered in the model. These in-
clude iron levels, hormones other than
erythropoietin, and neural stimulation, as well as
inhibitors and activators of erythropoietin
Although it may be desirable to include these
effects in future model applications, quantitative
information regarding them is presentl) lacking or
the need for their inclusion is not yet warranted
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2. The model has a limited representation of
bone marrow red cell production. For example, it
does not include the full maturation cycle from
multipotential cells to denucleated red cells.
Furthermore, it has no means of predicting
reticulocyte index.
3. The model does not include extrarenal
t:rythropoietin production or extramedullary
erythropoiesis These factors are of much greater
importance in the mouse than in the human.
However, sufficient quantitative information is
lacking for inclusion in a mathematical model
4 Blood viscosity and blood volume changes
are known to influence blood flo g and. thereby,
tissue oxygenation These effects are not explicitly
represented in the model (refs. 11141 and 111-82).
5 Overall oxygen transport is under the control
of homeostatic mechanisms in addition to the
erythropoiesis system. Thus, some of the fixed
parameters of the model such as blood flow, capil-
lary diffusivity, arterial oxygen tension, ptuma
volume, and oxygen -hemoglobin affinity can be
considered variable elements of circulatory, ven-
tilatory, biochemical, and fluid regulatory feedback
mechanisms that are beyond the scope of the pres-
ent model's design objectives.
Larger models that incorporate many of these
features are a.aildble. and these have been shown
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PART B.
CETAILED DESCRIPTION OF THE MODEL FOR REGULATION
OF ERYTHROPOIESIS
1
j
was ori g inall y written as part of a more comprehensive chapter on
yet unpublished. Figures, tables, equations,
left intact from the original.
B-1	 ^^^^
models Jwhichr is as
references have been
* Detailed Description of the Model for Regulation of Erythropoiesis
The model de veloper! for the space - flight
hematological program was designed to examine
the relative influence of the controlling factors of
erythropoiesis on total red blood cell (R8C) mass.
The formulation was based on the generally ac-
cepted concept that the overall balance between ox-
ygen supply and demand regulates the release of a
hormone, erythropoietin, from renal tissues sensi-
tive to oxygen tension levels and that this sub-
stance in turn controls bone marrow red cell pro-
duction (refs. B-I to B-3).
The amount of oxygen delivered to the tissue is
accounted for in the model by the combined in-
fluence of several factors: hemoglobin concentra-
tion, lung oxygenation of hemoglobin, blood flow,
and oxygen-hemoglobin affinity (ref. 114). From
this amount of oxygen, a certain fraction is -x-
tracted by the tissue, depending on the oxygen de-
mand parameter. Oxygen enters the cellular spaces
by diffusion along an oxygen tension gradient be-
tween the venous capillaries and the cell ( ref. B-5).
Decreasing the oxygen supply in relation to the de-
mand reduces tissue ox, Ren tension which is, in
effect, monitored by a local oxygen detector (ref.
B-6) and results in increased rates of erythropoietin
release ( ref. B-7). Erythropoietin is released into
the general circulation, and its final plasma con-
centration is determined by its rate of release, its
volume of distribution, and the rate at which it is
metabolized ( ref. B-8), the latter being represented
in the model by the hormone plasma half-life. The
target organ for erythropoietin is the bone marrow.
The production rate and release of red cells in the
model are determined by the plasma erythropoietin
concentration (ref. B-9). A time delay exists be-
tween marrow stimulation and red cell release (ref.
Z-10). Destruction of cells is represented in the
model by a lifespan parameter. Hemoglobin cor.-
centration in blood is based on the addition of new
cells to existing cells and plasma.
It is known that red cell production is modulated
by factors other than those considered in the
model. Th-se inc l ude iron levels (ref. B-11), hor-
mones other than erythropoietin (ref. B-12), neural
stimulai (ref B-13), as well as inhibitors and ac-
tivators of erythropoietin ( ref B-14). Although it
mad be desirable to rlude the- effects in future
*This section
physiological
rumbers, and
model applications, quantitative information
regardi:tg them is presently lacking or the need for
their inclusion is not yet warranted.
Overall oxygen transport is under the control of
homeostatic mechanisms in addition to the
erythropoiesis system. Thus, some of the fixed
parameters of the model such as blood flow, capil-
lary diffusivity, arterial oxygen telsion, plasma
volume, and oxygen-hemoglobin affinity can be
considered variable elements of circulatory, ven-
tilato.y, biochemicai, and fluid regulatory feedback
mechanisms that are beyond the scope of the cur-
rent mode'. 's design objectives. Larger models that
inccrporate many of these features are available
and these have been shown to be compatible with
an eryt.`, ropoiesis subsystem model ( ref. B-15).
Although these mechanisms are not included ex-
plicitly in the present erythropoiesis model, their
influence can t ., tested, in most cases, by manual
alteration of existing model parameters.
MATHEMATICAL DESCRIPTION OF MODEL
Oxygenation of Blood
The oxygen concentration of arterial blood
(neglecting oxygen dissolved in plasma) after
passage through the lungs can be expressed as the
product of the carrying capacity of a grate of
hemoglobin (CHbO: i.e., 4 moles O, per mole Hb),
times the hemoglobin concentration (Hb), times
the fractional degree of oxygen-hemoglobin si tura-
tion (SO)- It is conver_lent to use hematocr t rather
than hemoglobin concentration as an index of red
cell concentration in blood. These quantities are
related by the mean corpuscular hemoglobin con-
centration, such that hfCHC — MlHcr. Therefore,
for arterial blood'
CQ O = Sa0 X Hb X CHbO
-VxHcrxA101C XCHbO
 
(B1)
Sae table G-1 for s ymbol definitions. units, and normal
values
Y
At full hemoglobin saturation, Sa o — 1.0 and equa-
tion (BI) then represents the maximum
oxygen-carrying capacity of blood at a given
hematocrit. In most instances, the parameters
MCHC and CHb0 will be invariant, so that the ar-
terial oxygen concentration is influenced only by
the hematocrit and hemoglobin uturation In prac-
tice, the arterial oxygen tension (?,,0) is assigned a
value,' and a corresponding value of S,0 is deter-
mined from the oxygen -hemoglobin equilibrium
curve (OEQ, an operation tha. can be expressed in
functional form as
Sao - OEC(P^O)
	
(B2)
Oxygen Delivery at Tissues
Oxygen transport at the tissue level is schemat-
ically represented in figure B-1. In the present
model, the tissue of concern is taken to be the
erythropoietin -p roducing cells known to be located
primarily within the kidneys. It has been assumed
thr ► the oxygen sensor as well as sites of
erythropoietin production are responsive to the
mean oxygen tension of the kidneys. This assump-
tion permits tissue oxygen tension to be derived
from an oxygen balance using blood flows, ar-
teriovenous oxygen concentrations, oxygen con-
sumption, and transcapillary diffusion resistances
common to the kidnevs, which are considered to be
a homogenous tissue.
'See table &1 for symbol definitions, units, srd normal
value
Capi l ty dill fUSivity, Kd_
C li o 	coo
oZ Corner
Capillary blood
B l ood flow Q n+	 ^►
FPVo
o2 partul	 p p	 w
Ptoonswe
0 - C,0 1 = K d (P,o - Pt
Rene) tissue fluid
v
FIGURE L-1.—Taco-eoorrtzmat stead?-pate soodel or renal
WSW s:yllesallwa.
The elements of tissue oxygenation were deler-
mined using a two-phase model consisting of capil-
lary blood and tissue fluid (ref. B-16). It is assumed
that the blood compartment is well mixed with an
oxygen partial pressure (P,O) equal to that in the
venous outflow. Oxygen diffuses from blood to
tissue along a gradient of oxygen partial pressure
(P,O — P,O), where Pro is the oxygen tension of
the homogenous tissue. The amount of oxygen
unloaded from the blood is given by the difference
in oxygen concentration between arterial and
venous blood (C,O — CO., At equilibrium, the
rate of oxygen transfer to the tissues is identical to
the tissue oxygen consumption ( V) and to the un-
loading of blood oxygen as determined by the ar-
teriovenous oxygen concentration. In other words,
Q x (CO O - C,,O) = Kd X (PLO - P10)
Rate of oxygen	 Rate of oxygei
unloading	 diffusion
= VM	 (B3)
where Q is the rote of regional blood flow and Ka is
the diffusive transfer coefficient between blood
and tissue.
The venous partial pressure may be obtained by
solving equation (133) for C,.O
C,0 = Ca0 - (Vm 1Q)	 (B4)
then computing venous hemoglobin saturation
from a formulation analogous to equation (B1)
S,O = C,01(Her X MCHC X CHSO) (SS)
and determining P,0 from the OEC, expressed in
functional form as
PO = OEC^,O)	 (136)
Tissue oxygen tension can now be derived from
equation (B3) as
P1 0 = PO - V* / Kd	 (B7)
The assumption of steady state in this formula-
tion implies rapid equilibration of oxygen in the
fluid phase and is not meant to sa%8est a constant
tissue oxygen tension during the simulation of an
I
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erythropoietic disturbance Since the erythropoietic
process itself has been modeled dynamically, the
hematocrit will be time-varying until red cell pro-
duction achieves its own steady state. In this
model, the hematocrit is a major influence on
alterations in tissue oxygen tension In addition,
other quantities in this algorithm (P.0, V., Ka,
P50, Q) are nonregulatory parameters and an also
influence tissue oxygen tension if they are
manually altered.
Erythropoletln Production and Distribution
Erythropoietin release is assumed to be
governed by the tissue oxygen tension. A limited
number of studies (refs. B-5 and B-17 to B-19) sug-
gest a relationship of the form'
F_ = Eo exp( G I P,O)	 (B8)
where F is the rate of erythropoietin production,
P,0 is the tissue oxygen partial pressure, G is the
gain or slope o f the function plotted linearly as the
natural Io^o^f Ep versus P 0, and Ea is the EP inter-
cept at Pro — 0. Setting E, — exp ( G) ensures that
equation ( Bg ) wil l a lways pass through the normal
operating point (EP — 1.0, P,0 — 1.0) irrespective
of values of G In certain cases, it may be desirable
to postulate a shift to the normal operating point as
well as gain, and in those cases, E. and G may be
adjusted separately. Figure B-2 illustrates the semi-
logarithmic relationship between tissue oxygen ten-
sion and erythropoietin production and shows the
influence of G.
The concentration of erythropoietin in the
plasma ( E) is a function of the rate of production
(Eii), the rate of clearance or destruction (Eiif), and
the volume of distribution ( P^). If it is assumed
that the rate of disappearance is proportional to the
plasma concentration (i.e., Ea — Ke x Ve x
where Ke — clearance constant — lot, 2/plasma
half-life), then the following first-order differential
equation an be written for the rate of change u,"
erythropoietin concentration (refs " and B-17):
dE _ LE - k E
	
(B9)
df	 e
0.4	 0.0	 0.1	 1.0
FIGURE &1.—Renal controller function for erythropoietin
production rate showing effect of gain G.
The steady-state concentration of E (at dEldr — 0)
is, therefore
	
Z(0) = Eo(o)/Ke a	 (B10)
Equation (B9) can be normalized by letting
E — EiE(o) and E,-- Eo/E (o) and substituting
equation (BI) into equation (B9):
d = MEp - ^)
l oge 2
_ 711n (Ep - E)	 {B11)
a form that has the:lvantage of being independent
of distribution volume and, further, independent of
erythr2poietin half-life (TEI f2 ) at steady state,
sinx E(o) — o(o). The value of TEI n — 12 hours
w,ts chosen for humans, but this •foes not appear to
be well established for normal sul,*ts (ref. B-20)
,..01--
t
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d
= 0..1
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` n
rThc bar over the symbols red resenu normalized values
Thus, X — XIX(o), where X(oi is thr control or pr!trestmen:
wndiuion and X is r value during the postcontrol or trt::rn.ni
phase The use of normalized values simp:irted comparison of
model response with data from vanoi:s laboratories
Red Blood Cell Production
An equation expressing the sernilogarithmic
dose-response relationship between red cell p ro-
B-3
. C+
duction (RCP) and erythropoietin concentration
(E) an be given as
RCP = G 2 lug, E + Pt 	 (B12)
As has been the convention, RCPand Ehave been
normalized with respect to their steaJy -state con-
trol values, Ch is the pin orsp of the response
curve, and A is the value of RCP when F — 1.0 and
is normally taken as unity.
The accuracy of equation (B12) may diminish
considerably at very low and very high values of
erythropoietin levels. For example, at decreasing
values of E approaching zero, the production rate
tends toward tninus infinity rather than zero,
whereas at high E values, the relationship does not
exhibit a maximal production that is known to ex-
ist. Therefore, two additional equations were for-
mulated and piecewise fitted to equation (B12) to
account for suppressed and maximal erythro-
poiesis (See fig. B-3.) Their precise description i-
somewhat speculative, although this bone marrow
function curve closely corresponds to the sigmoid
shape A most biological dose -response relation-
ships (ref. !x-21) and to those observes by others
for the bone marrow (refs. B-22 to B-24).
In the present study, it was assumed that there is
no basal production of red cells unless erythro-
poietin is present (i.e., P,, — 0). Maximal red cell
production is assumed to be six times normal (ref.
B-17) (P,,, — 6) and the upper limit of accuracy of
equation ( B12) was arbitrarily chosen at RCP — 5.
Iron uptake studies of red cells indicate a bone
marrow transit time for red cell production of 3.5 to
4.5 days (ref. &]0). This effect was included in the
model using a simple first-order time delay' with a
time constant TBAf . The inclusion of this transit
delay clearly improved the realism of the dynamic
response of the model, especially following sudden
changes in tissue oxygen tension.
Red Cell Destruction and Rod Cell Russ
The lifespan of the red cell dictates the destruc-
tion rate of cells. A model of red cell destruction
'If Y is the steady-state value predicted from a dose-
response relatwnthip, rhp n the response dNayed With a time
constant T is Ohtair_-d by the solution of the differential eQur
tion T dWdi + , — ► In finiie difference for m, suitable for uera-
live compute solution. this becomes r — y, + 1 Y — O(HIT)
where H
	
inicsration step size, n - tatue of , at the Al, ners
Iron, and	 — value or , at the , + Ith iteration
was assumed in which cells are destroyed randomly
and no cells survive past a given lifespan (ref.
&25) In that case, the ►ate of destruction (RCD) is
simply proportional to the amount of cells present
at any time. If that amount is given as RCM, then
the rate of red blood cell destruction will be
RCD = K,-RCM
= loge 2 -RCMI TRC,,
	 (B13)
where TRCI12 — red cell half-life and K, — red cell
clearance constant — loge 21 :rRCtn. At normal
values used in the model, the rate of red cell
destruction is 1.1 percent of the total amount pres-
ent or 22 ml of packed cells/day.
The instantaneous change in total circulating red
all mass is the net difference between red cell pro-
duction and red cell destruction rates:
d(RCM) = RCP - RCD	 (B14)
dr
The quantity RCPis obtained from^iation (1312)
using the transformation RCP — RCP x RCP(o),
where RCP(o) — RCD(o) — K,-RCM(o).
Finally, the current value of RCM, obtained by
integration of equation ( B14), is combined with the
plasma volume to obtain the whole-body
hematocrit of the circulation:
Hcr PV + ROf
	
(1315)
and the feedback loop is closed.
The Renal/Bona-Marrow Axis as a
Proportional Contronw
A more visual understanding of the relation-
ships for renal and bone marrow function cim be
obtained by determining the overall dose-response
curve of the combined kidney /bone-mwTow axis;
that is, the relationship between tissue oxygen ter.-
sion and red cell production. The results are shown
here only for the midrange of erythropoietin pro-
duction and were obtained by mathematically com-
bining the renal function (eq. (B9)) with the
steady-state plasma distribution function of
erythropoietin (eq (B1 I), E — E,) and the bone
marrow function (eq. (B12)). In this way,
IiI
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FIGURE &3-41one Barrow controller function for red cell production rate showing equations used to pWCVWtse fit the dose-
response curve and demonstrating effect of gain Gn.
erythropoietin is eliminated as an explicit variable-,
i.e.,
RCP = G(1 - Pr0)	 (for Pro- < 1) (B16)
where G — Cn x &. This is a simple inverse linear
relationship that has previously been used in the
models of Guyton et al. (ref. B-15) and Hodgson
(ref. B-5). In this form, the Bair of the renal/bone-
marrow (open loop) system is seer to be the prod-
uct of the two gain factors, Cr and G, Similar
(although nonliuear) gain-product relationships
were obtain5d for the extreme of hyperoxia and
maximal hypoxia. The results of this analysis have
been plotted in figure B4 for a range of values of G.
This function represents the entire controller cir-
cuit of the erythropoiesis model. In general, hypox-
ic tissue is predicted to have a greater effect on red
all production than hyperoxic tissue, as indicated
by the relative slopes. However, at higher gain fac-
tors, the suppression of erythropoiesis can be con-
siderable for relatively small increases in tissue ox-
ygenation.
Equation (B16) is a typical controller function
for a linear proportional control system in wh ich
the actuating error signal is the deviation of Pro
from its control value (unity) and Gis the constant
of proport ionality or controller gain The control
value of PrO is taken as an arbitrary reference
standard and is not meant to imply that there is an
internal set-point It becomes clear from this con-
trol function that the primary controlled variable is
tissue oxygen tension rather than red cell produc-
tion, red cell mass, or hematocrit, which can be
considered controller variables. The control system
always adjusts the controller variables in a direc-
tion that returns the controlled variabie toward
normal after an initial load disturbance. (See fig.
A-1 in app. A.)
The controller gain is a major determinant of the
final feedback compensation following a dis-
turbance and, within limits, the speed at which a
disturbance is corrected. Although increasing the
gain increases the feedback effect, it may be at the
sacrifice of an oscillatory approace to the steady
state. Systems of higher order than this one will
tend to become unstable as controller gain in-
creases Oscil!ations in the erythropoiesis system
are known to occur in special cases, and analysis of
these systems in terms of control system theory
has proved to be rewarding ( refs. B-26 and 8-27).
Modal Operation
The system of equations (BI), (B2), (114) to
(B8), and (B11) to (B15) is solved by computer
simulation using an iterative procedure. Equations
(B' 1) and (B14) are integrated numerically using a
simple Euler algorithm (ref B-28) ti: i nitial condi-
tions E(o) and RCM(o), respec t ively T1e program
is currently implemented o.. a Univac 1110 and a
B-5
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FIGLRE B4—Combined renal bone -marrow controller function showing effect of tissue o x ygen tension on erythropoiesis for
various values of overall gain G.
PDP 11/40 using Fortran language. Remote ter-
minals including graphic display of the simulation
responses (and experimental data simultaneously.
when desired) have greatly facilitated user Interac-
tion and have enhanced the convenience of model
validation.
Perturbing the model away from its normal
steady state (initial conditions) is accomplished by
altering one of the model parameters.' These quan-
tities are normally constant in value but can be
altered during a run to simulate either independent
stress stimuli or long - term regulatory adjustments.
Thus, hypoxia may be simulated by decreasing ar-
terial oxygen partial pressure (p02), and hemolysis
?he term "parameter" is used to denote time-invariant
quantities ths , are not altered b% the dynamic properties of the
model as opposed to "dependent vanab:cs` that are time-vat)
ing and foam the connecting links o' the feedback arcut: 6 e .
Pro E RCP Ho etc t
may be simulated by decreasing the red cell
lifespan In some cases, alteration of more than one
parameter may be desired as in the simulation of
altitude hypoxia which involves a primary change
in arterial p0: and a compensatory shift in oxygen-
hemoglobin :fftnity (P50). Farameter values may
be time-invariant with values fixed before a simula-
tion run or the% ma y be entered as a function that
varies with time as the run progresses. Experimen-
tal data ma y
 he used to drive the model in this
fashion. Thus, it is possible to simulate a wide
variety of stresses and to test a large number of hy-
potheses regarding regula ! ing mechanisms.
Parameter Estimation
Table B-I lists the values of the system
parameters. chosen as representative of the human
system Also shown are the steady-state control
B-6
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T48LE 84.—Parameters and Initial Condlrrons
jymbol
	
Di	 1'olw•	 (nrn
Parameters
CH60 Carrying capacity of hemoglobin 1.34 ml 0,/g Hb
E. Intercept of erythropoietin function 2009 x normal
G, Gain of erythropoietin function 3 Nondimensional
G, Gain of red tell production function 2 Nondimensional
K, Capillary diffusivity .567 ml 0, min - ' mmHg-'
415 ml O, min — kPa`
MCHC Mean corpuscular hemoglobin concentration )75 It Hb/ml RBC
P.O Oxygen tension in arterial blood 950 mmHg
12.67 kPa
Ph Plasma volume 10 Liters
P. Maximum production rate of red cells 6 x normal
P. Minimum production ra,- of red cells 0 x normal
P, Normal production rate of red cells I x normal
P50 Oxygen tension of hemoglobin at 50 percent saturation 26 7 mmHg
356 kPa
Q Rena; blood flow 1	 2 Liters/min
TBM Bone ., arrl» ::ansi: time 4 Days
T£,^, Plasma half-life of erythropoietin 12 Hours
TRC, Red ce ! ' half-lire 63 DaysV. Oxygen urt]ke of kidnc s 20 ml 0,/min
Initial conditions
C.O Oxygen content o'arterial blood 196 ml 0, 1 100 ml blood
C.,0 Oxygen co-):ec' of venous blood 114) ml 0,100 ml blood
E_ Erythropoie:in concentration in plasma 1.0 x normal
Er Eryth,opotetin production rate 10 x normal
Hrr Hemalocri: 40 ml of packed RBC1100 ml
blood
P,O Oxygen tension it-. renal tissue fluid 20 mmHg
267 kPa
P,O Oxygen tension in venous blood 55 3 mmHg
7.31 kPa
RCAF Red cel: mass 20 Liters
RCP Production, rate of new red blood cells ml of packed alts/day
S.0 Saturation of arteria; hemoglobin with oxygen 976 Percent
S,0 Saturation ci venous hemoglobin with oxygen 893 Percent
x
i
I
I
values (i.e., initial con,litions) of the major de-
pendent (output) variables. The precise values of
most of the quantities shown in table 8-1 are not
critical, however, to the general behavior of the
model's response when expressed in percent devia-
tion from control An exception to this occurs for
the highly nonlinear functions such as the oxygen
equilibrium curves and the renal and bone marroA
function curves The location of the operating point
on these curves can change the nature of the output
response Also, the shapes of these curves, as
defined b) the gains and threshold parameters ace
critical to t he magnitude of the response These will
be discussed next.
An equation for the oxygen equilibrium curve
was obtained from Aberman et al (ref. B-29) Their
stud) included a computer algorithm that converts
oxygen tension to saturation and, with iteration,
oxygen saturation to tension The agreement be-
tween measured and computed values is claimed to
be better than 0 2 percent In addition, the
algorithm includes the capability of altering P50
values. (See fig B-5 )
Analysis of Adamson's data (ref B-18), from
which the erythropoietin release function was ob-
tained, leads to an estimated value of G — 2.8 In
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FIGURE B-5—Ox ygen-hemoglobin equilibrium curves drawn
directly from computer model output showing effect of chang-
ing the PSO parameter. The PM value is the oxygen tension at
which SO percent of the bemoglobin is saturated and is,
therefore, an index of oxyhemoglobin arfiniq. The position of
the OEC may vary In accordance with renown effects of hy-
drogen ion. CO;. temperature, or 23-DPG tdiphosphogl y cer-
atet. The effects of DPG are of interest because of its possible
contribution to enthrokinetic changes during bed rest or
weightlessness.
simulation studies of bed rest and h, • poxia (refs
&30 and &3.), values of &. were determined by
parameter estimation to range from 2 to 5. No data
exist to confirm these estimates directly. It is per-
missible to use the gain factors as adjustable
parameters, within reasonable limits, in order to
test hypotheses and possibly provide improved
agreement between model and experiment data In
addition to the gains or sensitivities, the other
parameters of these functions (Eo, Po , A) that can
be thought of as threshold indices are also not well
known and are available for parame ter estimation
during a simulation. Changing these latter quan-
tit es implies a shift of the normal operating^oints
(( EP — I,P,0 — 1) for rig. B-2, (RCP — 1,E — 1)
for fig &3) The value of Kd was obtained from
equation (137) by dividing the oxygen uptake by
P,0 — P,0 The value f P,0 was arbitrarily
assumed to be 2.67 kNW (20 mmHg), and P,0
was computed from equations (BI ). (B2), and (114)
to (86)
Steady-State Errors
It is an inherent property of most biological
homeostatic mechanisms in general and propo-
tional contro l systems in particular that there will
be at least s ,)me residual steady-state deviation
from the normal operating point when the system
is disturbed by a constant load. This "steady-state
error" will vary in size depending on the gain of the
system and the magnitude of the load disturbance.
The sensitivity coefficients of table 111 .6, for exam-
ple, indicate the steady-state errors of red cell pro-
duction resulting from small changes in parameter
disturbances
A basis for under: i.nding steady-state errors in
the current model is as follows At any equilibrium
state, the term dRC.kf1dr in equation (19114) must be
identically zero Therefore, equations (B13) and
(B14) imply that, at steady state, daily red cell pro-
duction and destruction ra!es are equal Further.
more, if red cell Itfespan is constant, a steady-state
alteration in red cell mass implies a proportionate
change in red cell production. Most load dis-
turbances are accompanied by changes in circulat-
ing red cell mass (fig. B- 1) This implies that red
cell production and one or more of the factors that
affect red cell production (including tissue oxygen
tension, erythropoietir., hematocrit, controller gain,
and set-point) must have incurred a stead y -state er-
ror, however small. It can be appreciated from
figure B-1 that steady-state errors in tissue oxygen
tension are reduced at the expense of larger errors
in red cell mass and hematocrit.
Steady-state analysis may also provide insight
into the independent determinants of the con-
trolled variable (ref. 8-32). Figure B-6(a) shows the
effect of tissue oxygen tension on red cell produc-
tion (the controller function of fig. B-4) and the bal-
ance between red cell production and destruction.
Feedback control ensures that the various elements
of the model are adjusted until the rate of red cell
mass change, dRC,4Y1dr, becomes zero and that
steady state is defined by this condition It is math-
ematicall) permissible to set dRCMIdr to equal zero
and work backward from this point to visualize
those factors that determine tissue oxygen tension
(fig B-6(b)) There are only two such fa )rs in our
model red cell destruction (which determines pro-
duction rate) and the relationship between tissue
oxygen tension and red cell production Only these
factors and those quantities that affect these factors
will ultimatel% determine tissue oxygen tension
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FIGURE 84.—Stetady -state analysis of Ions -term determl-
nsots of tissue oxygen tension. (a) Segment of feedback circuit
that results in the term dRt f/drbecoming zero at stead. state
when destruction and Production rates are equal. (b) Reversal
of diagram In figure 94(a) starting f rom the zero pint and
showing matbematicall? equivaieni influences on tissue ox-
ygen tension.
Experimental evidence is severely lacking on the
de)er mi nants of the shape of the controller func-
tion curve, although it appears that it may be under
the influence of neural and biochemical factors.
(See subsection entitled "Discussion.") The factors
that are responsible for normal red cell destruction
are also not apparent (ref. B-10). Except for overt
pathology, rates of destruction are generally con-
sidered to be a constant fraction of total circulating
red cell mass.
Aside from these experimental shortcomings, it
is important to note that the factors usually agreed
to play a role in acute changes of tissue oxygenation
(i.e., blood flow, capillary diffusivity, oxygen up-
take, P50, hematocrit) are not represented between
the zero point and the tissue oxygen point in figure
B-6. Although they may be considered dependent
variables in the system, none of them, from a
mathematical point of view, are independent deter
minants of the final level at which the tissue ox-
ygen tension will stabilize in the steady state.
Although dRCM/dr will always return to its initial
zero value, the tissue oxygen tension may exhibit a
steady-state error due to the inherent properties of
the control system in the face of a constant dis-
turbance However, based on the preceding
analysis, the authors believe that ever, tissue ox-
ygen tension will return to its initial value (zero
steady-state error) when both of the following con-
ditions are satisfied (1) a constant daily rate of red
cell destruction and (2) a constant controuer rela-
nonship between tissue oxygen tension and red cell
production
As an example of the last point, a simulation of
hypoxia was performed (fig B-7) in which arterial
oxygen tension was set at some low value for the
entire run and red cell destruction was clamped at
its control value of 12 ml of packed cells/day.
Tissue oxygen tension decreased and then began to
return toward normal as red cell production and
hematocrit rose, similar to the simulations with the
intact system shown in fa:tre B-7(a). However,
since the destruction rate was not permitted to in-
crease, a greater net rate of red cells entered the cir-
culation than would have 3ccurred had destruction
rate rose in accord with the mass action law c,f
equation (B13). As a result, tissue oxygen tension
continued to rise and red cell production rates
declined. When the system reached its new steady
state, red cell production and tissue oxygen tension
returned exactly to the prehypoxic control condi-
tions in accord with the concepts discussed in the
previous paragraph This was despite an arterial ox-
ygen tension that was still significantly depressed
and at the expense of hematocrit and circulating
real cell mass that were considerably above normal
It is perhaps easy to visualize that a primary
change in destruction rate, as in hemolytic anemia,
leads to secondary changes in tissue oxygen ten-
sion It is more difficult to conceive of destruction
rate being a determining factor of tissue oxygena-
tion in a stress like hypoxia in which it appears, at
first, that the decreased oxygen loading of arterial
hemoglobin is the primary stimulus for hypoxia.
However, it is important to distinguish between the
initial stimulus of the acute phase, which blood pO:
is contro!ling, and the ultimate stimulus of the
steady-state condition, which destruction rate (and
controller function) Is controlling These conclu-
sions from a theoretical model may warrant further
experimental examination. The simulation of
hemolytic anemia presented in Section VIII illus-
trates the capability of the control system to
minimize stead y -state errors.
DISCUSSION
Renal pO: Sensor
A major assumption in the controlled system is
the description of the renal oxygen detector The
evidence strongly indicates that the balance be.
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tween oxygen supply and demand at intrarenal
sites is the primary _ '^lulus for erythropoietin
release (refs &7 and B-33). Furthermore, these
detector sites must monitor venous or tissue p0:
rather than arterial p0: since anemia or increased
oxygen-hemoglobin affinity lead to increased
erythropoietin production without significantly
altering arter i al blood oxygen tension (refs B-5,
&34, and B-35) The receptors sensitive to tissue
p0: may be those cells that excrete erythropoietin
or its precursor (ref. &13!. The present model is in
accord with these concepts.
It has been suggested that the kidney has unique
characterist • cs that enable it to function as a sensi-
tive oxygen chemoreceptor and, in particular, be
responsive to changing hemoglobin levels The
peculiar renal microcirculation and the uniquely
low arteriovenous oxygen difference provide a gra-
dient of tissue oxygen tension that amplifies
changes in blood oxygen delivery ( refs 9-14 and
B-35) In addition, the autoregulatory features of
the kidney ensure that blood flow and oxygen up-
take are effezio-ely stable over a wide range of ox-
ygen tensions and blood pressures (refs B-36 and
&37) Morw%er, if blood flows should be altered,
the kidney, in contrast to other organs, will exhibit
proportionate changes in oxygen uptake (ref B-38).
This means that the ratio ;,,IQ (the only term in
which blood flow appears in the model (eq (B4))
may be relatively constant, and renal blood now
would not be expected to markedly influence tissue
oxygenation
The preceding discussion suggests that the
powerful influence which oxygen uptake, per se,
was found to have in the model (fig. &I and table
&I) may be mitigated in the real system by concur-
rent changes in blood (low. Similarly, it is possible
that an clevation of V, by whatever cause, pro.
motes tissue hypoxia and results in local regulatory
increase's of Ks, the effective capillary diffusivity.
This is now known to be true for skeletal muscle
(ref. B-39) but has not been confirmed for the
kidney Such regulation would, however, further
dampen the effect of oxygen uptake because Kaap-
pears only in the ratio 1'17 IKa in equation (B7) It
may be desirable to add these local regulatory
effects—between oxygen uptake, blood flow, and
capillary diffusivity—to the model A current alter-
nate approach is to assume they are constant and to
examine the;- influence, if the data so suggest, to
i
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improving the accuracy of simulation Under these
circumstances, and in accord with equations (B1)
to (B7), tissue p02 would be a function of the
hemoglobin concentration of the blood, the arterial
oxygen saturation of hemoglobin, and the shape
and position of the OEC (ref. B-6)
It should be emphasized that the site of the in-
tracenal detector has not yet been confirmed and
that the quantitative aspects of its oxygen supply-
demand balance (including direct measurement of
P,0) remain unknown. Justification of this seg-
ment of the model is based on indirect evidence,
gross characteristics of the kidney as a whole, and
determinants of tissue oxygenation derived from
other tissues.
The use of a steady-state formulation for tissue
oxygenation (eqs. (1911) to (B7)) in a dynamic
model is justified because, in the well-perfused
kidney, equilibrium of oxygen tension due to pure
convection and diffusion ma y
 be achieved in the
order of seconds to minutes following a load dis-
turbance This can b,• compared to the much slower
changes of the erythropoietin distribution or bone
marrow red cell production process Estimates of
true equilibration times were obtained from the
non-steady-state version of this algorithm (refs
B-16 and B-40 ) that was originally employed in the
NASA studies The stead)-state description per-
mitted the use of a larger integration step size in the
numerical algorithms and increased the solution
speed significantly without decreasing the accuracy
of the response for the long periods of time in
which the investigators were interested
Bone Marrow Controller System
An accurate description of the relationship
governing erythropoietin release is not yet availa-
ble, presumably because of the difficulty in measur-
ing intrarenal oxygen levels and the uncertainty
surrounding the specific location of the receptor
cells The formulation used to relate tissue oxygen
tension to erythropoietin release is in accord with
the study of Adamson (ref. &18), who found a
semilogarithmic inverse relationship between daily
urinary erythropoietin excretion and hernmocrit in
humans A parallel between urinary and plasma
erythropoictin (ref B-7) as well as between
hematocrit and tissue p0: (ref &41) was assumed
in deriving equation (88) A similar relationship
has been used b) Hodgson (ref B-5), whereas Perer
(ref B42) has derived a linear relationship and
Mylrea and Abbrectt (ref &17) have used arterial
oxygen-hemoglobin concentration 6 f_ Hb x S,0)
rather than tissue oxygen tension as the inde-
pendent variable At the present time, sufficient
data do not exist to reveal the precise shape of this
function
Measurement of plasma erythropoietin has, un-
til recently, been restricted to levels above basal
(ref B-1). Therefore, no data are available to ;on-
firm the relationship to reduced release rates of
erythropoietin. This region is of particular interest
because of its application of simulation to bed rest,
space flight, and related disturbances in which
chronic elevation of hematocrit follows plasma
volume shifts.
There is an abundance of information demon-
strating that in experimental animals, a linear rela-
tionship exists between red cell production and the
log of erythropoietin concentration (eq. (1312)).
This has been observed, for example, in bioassay
animals in which doses of erythropoietin are in-
jected either singularly with iron uptake used as the
index of erythropoietic activity (refs. 8-2 and B-24)
or administered at frequent intervals for up to
several weeks with production rate expressed in
terms of increased red cell mass (refs B-9 and
B-23) It is reasonable to assume that a similar dose-
response relationship exists for the human,
although confirmatory evidence is lacking In vivo
estimates of the human function curve, especially
for the suppressed erythropoiesis range, will be
possible as erythropoietin becomes available in
large quantities and as more sensitive assay
methods for this hormone are developed.
The shape and position of the ren31 and bone
marrow function curves have been found to be cru-
cial elements in the control of er)-thropoiesi ,, in
general and in the long-term contro! of tissu e: ox-
ygenation in particular. Model parameters have
been incorporated to allow for shifts in sensitivities
and thresholds away from the normal operating
points Values of controller sensitivities have not
been well established in the human by direct
methods and only to a limited extent in experimen-
tal anirnzis (ref B-5) Several studies sugges, that
alterations in these parameters occur during certain
physiological stresses such as dehydration and h )
 -poxia (refs B-43 and B-44) and during pathological
disturbances such as abnormal hemoglobin (ref
B-34), erythro:ytosis (ref &18), and hemol%tic
anemia (ref B45) It appears that the rate of red
,f
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cell production is determined not only by the con-
centration of cry thropoietin but also by the size of
the stem cell pool (ref B-46) IF this is true, the
bone marrow response to a given dose of
erythropoietin should be greater than normal (I e ,
an effective increase in tn). The availability of iron
to the erythron may also influence this function
(ref. B-11) Certain hormones, such as androgens,
as well as neural stimuli are assumed to exert their
effect on erythropoiesis by thei r modification of
erythropoietin release (i.e., an effective change in
G, refs. B-12 and 8-13). It is possible, using the cur-
rent modt.l, to predict these parameters within nar-
row limits provided both the dynamic behavior of
erythropoietin and red cell production ates are
measured simultaneously during hematologic
stress unfortunately, such data are seldom availa-
ble, especially for humans.
General Comments
Feedback regulation of tissue oxygen tension is
accomplished solely- by Adjustments of hemoglobin
le , els resulting from the output of a renal/bone-
marrow controller. Other parameters that are
kn.)Mn tc effect acute changes in tissue oxygena-
tion are Incorporated explicitly In the model but are
nonregulator ► in nature and can be altered
manual]% to test various hypotheses Similarly. the
characteristics of the controller can also be adjusted
to test their effect on long-term control of tissue
p0: and red cel! mass Such parameter adjustment
(other than for the primary disturbance) has not
been found to be essential, in most cases, to simu-
late the basic behavior of the dynamic and steady.
state response However, fine tuning of parameters
is required to scale the model output and achieve
closer agreement with experimental values. In
some cases. these studies indicate the need to pro-
pose additional regulatory elements to provide, for
example, a more realistic simulation of the
ery thropoietin response to hypoxia Other features
of a general nature have also been identified that
will increase the utility of the model even further,
including (1) the effect of blood volume and
viscosityii, or.oxygen transport and (1) a description
of stem ceG kinetics and reticulocytosis (ref B47)
FORMULATION OF MOUSE MODEL
System Parameters
The con.puter model for erythropoietic control
was adapted to the mouse system by altering
system parameters originally given t'or the human
to those that more realistically represent the mouse
(ref B148) Parameter values were obtained from a
variety of literature sources as indicated in table
B-11 The immediate applica r.ion of the mouse
model was the study of the mouse u a potential ex-
perimental model for space flight. Data for the
simulations were obtained from C. D. R Dunn's
experiments at the University of Tennessee
Memorial Research Center and included studies of
dehydration and hypoxia The strain of mice used
in these studies was C3H with an approximate
weight of 25 grams Parameter values were chosen
for this strain where possible In certain cases, the
literature values were superseded by values ob-
tained dlrectl^ from Dunn's studies In a few cases,
mouse data were not available and data for the rat
were substituted A comparison of system
parameters for the mouse and human models is
shown in tab'- B-11. Aside from the obvious
differences expected in fluid volumes, blood flows,
and metabolic rates, larger differences were ob-
served in the following erythrocyte lifespan (126
days vs V days),' erythropoictin half-life (12
hours vs 3.25 hours), and normal arterial p0:
(126 71 k.,N/m : (95 mmHg) vs. 104 kN/m' (78
mmHg)) The shorter lifespan of the mouse fed
blood cells implies a turnover of erythrocytes
which is sixfold faster That is, the daily rates of red
cell production and destruction ( as wel! as
reticulocyte index) are approximately six tames
higher in the C3H mouse than the human' Other
parameters which were found to be more similar
between the two species were as follows hems-
tocrtt (40 vs 45), mean corpuscular hemoglobin
concentration (0.375 vs. 0.30), and maximum ox-
ygen -carrying capacity of hemoglobin (1.34 vs
141)
Tirst and second numbers !n parentheses refer to human
and mouse rMectively
'T>prca' %alues for mice red cel lifespan round to the
lueearurt nd ale onh a threefuld rncreasc Values used here
were 'ouni t, , Dunr to be much dJreren in the C3H strain
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Although the arterial pO. in the mouse is much
lower than in the h( -tan, the oxygen saturation of
hemoglobin of both species is nearl3 identical (97
percent vs 99 percent) This is a result of the dis-
tinctly different oxygen-hemoglobin dissociation
curves shown in figure B-8 and reflected in the
different P50 values (3.53 kN/m^ (26.5 mmHg) vs
5.2 kN/m' (39.0 mmHg)) The P50 differences Im-
ply that, at the same level of tissue oxygen tension,
oxygen is more easily unlor-ded to the mouse than
in the human I: should be noted that the normal
pO2 of arter:al olood assumes; hire (104 kN/m .' (78
mmHg)) was )btatned from rat data (refs 8-51 and
8. 56) and has been used to a previous mode! vali-
dated for the mouse with reasonabl y good results
(ref B•17) Nu corresponding mouse data could be
located.
values for renal blood now of th- mouse were
not available, and data from rats were used (6 ml
rein - ' g'' tissue)
!it -algid Parameters
Some parameters of the mouse model differ con-
siderably from the human model because of scaling
factors Plone The values used in the model are
given on an absolute basis for th e whole anima!
rather than as a specific propert y In terms of '-per
gram of tissue - In terms of specific units, the
differences betwec,, tht mouse find human system
are much smaller, as shown to table B-III
r `
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Huma n Alousf VO- as h'"man Mousr (!nm
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p and volume RM 1 4C ml 71 4 560 mt/k1 bod) w 
Rena bbsod (low 1200 183 mUmtn 4 21 6 10 ml mtn-'
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Oxygen Balance
The balance of oxygen supply versus oxygen de-
mand is crucial to the feedback regulation of
erythropoiests A parameter reflecting this com-
plex balance is the tissue oxygen tension that is
believed to govern the release of erythropoietin.
The oxygen balances for the human and mouse
systems as used in the model are given in table
B-IV.
Oxygen consumption per gram of renai tissue in
the mouse is approximately twice that for the
human (Overall total oxygen consumption per
gram body weight is nearly seven tim es greater in
the mouse.) This higher oxygen demand of the
rr:)use is satisfied in two ways in the model. First,
there is a 50 percent greater efficiency in oxygen
extraction as indicated in table B-IV. (Note that, in
both species, the amount of oxygen delivered at
rest is more than sufficient. i e , roughly 10 times
that required by the tissues ) Second, there is a 30
percent higher blood oxygen supple per gram of
tissue because of greater tissue blood flow in the
mouse.
The normal tissue oxygen tension is arbitrarily
assumed to be identical in both model systems, i.e.,
2.67 kN/m' (20 mmHg) The equation describing
oxygen diffusivity to the tissues from venous
capillaries is given in the steady state as
Net oxygen delivery = tissue oxygen consumption
= (p0 2 ,vein - p0,,tissue) X K
where K — conductivity coefficient — 0: diffu-
sivity times the capillary surface area. The ratio
Kman/Kmoc^. would be expected to reflect the sur-
face area ratio between species if diffusivity is
assumed f milar in mouse and man. Therefore, if S
is capillary surface area, then
5,,,jr	 Kma r.
Sn.ol,.	 4 ,,ouu
(O:. wa wupnon)m,, 	 (pO2 sin	 p0 : tissue) `m,r
'(` 114 run 
x 
157 5	 201 n1mHe
0 04 M; 'min	 (St, a	 '-01 mmHg
= 51`
T4BLE B-ll'.—Ox. t.grn Balance a. Kidne ►
0, sidpr% equals
	
A'rdnt,	 Q tnau,BF x 0. :JnC en:!Tr7r
Gl dernona
Pll'i-ete•
	Humor	 Mouse	 Units
Ox ygen demane	 20	 0 CW	 m10,!mm
	
0 1 3	 153	 MIO,mtr. - 'a
Ox ,vger suppi.,
pO, arteria l 	95
	
hl	 mmHg
	
1.1 6'	 104	 Olt
t0.. anenal	 914	 91 6	 Percent saturation
0 ; eoncertrat,or 	 196
	 118	 ml0,/I,ter blood
BF	 1200	 1 13	 m! blood'm,n
0, suppl; rate	 235	 34'	 ml 0,/min
	
139	 1 143	 m10, min
oxygen venous
p0, venous
	 56	 57	 mmHg
	
'1'	 ^b	 Oil
s0.. venous	 fo	 io	 Percen, vwrat,on
p0, I,ss„c	 20	 2(1	 mmHg
	
:6'	 ?6	 aPa
Percen. ox,Sc r 	1 '	 11 a	 Perrent
euracuor - 40
dem.nJ, , 1 1 su^r
This is in good agreement with the surface area
ratio of 650 of the glomerulus derived from data in
reference B-54 (p 1 741, lending support to the
general representation of the kidney in the com-
puter model.
Functional Relationships
Three functional relationships are included in
the computer model ( 1) oxygen -hemoglobin
equilihrium curve (OEC), (2) erythropoietir
release as a function of tissue poi, and (3)
erythrocyte production rate as a function of
erythropoietin concentration. The first of these is
shown in figure B-8 and will subsequently be de-
scribed in detail The form of the function curves
for erythropoietin and red cell release will be
assumed identical in the mouse and human
models There is no reason at the present time to
take issue with this assumption, particularIN since
the bone marroN function waS originally obtained
from the mouse These curves (as shown in figs
B-15 1
e
s
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B-Z and B-3 and as used to the models) are repre-
sented in normalized form 6 c , percent of control)
so that any species may be represented The gain
factors G and G. representing the slope of the rela-
tionships, ma) be different between species This is
of little concern In the basic design of the model
because these parameters will be adjusted during
the simulation process and their actual values will
be estimated by "fitting' the model output to the
experimental data
The equation describing the sigmoidal OEC is a
form of the Hill equation and is shown in the insert
of figure B-8 The two solid lines represent human
and mouse blood, respectively, and were recently
obtained from blood samples of the C3H mouse
(ref BA9) The value of F50 is explicitly stated in
the equation so that shifts in oxygen-hemoglobin
affinity may be easily described. The value of the
exponent A, found from the best fit of the mouse
curve, also provides a good fit of the human curve
as shown In figure B-8 Thus, the only difference
between the equation describing the human and
mouse OEC is the value of P50.
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